rimactan 300 mg kapsel, hård
2care4 aps - rifampicin - kapsel, hård - 300 mg - propylenglykol hjälpämne; rifampicin 300 mg aktiv substans; laktosmonohydrat hjälpämne - rifampicin
rifampicin ebb 300 mg kapsel, hård
ebb medical ab - rifampicin - kapsel, hård - 300 mg - propylenglykol hjälpämne; rifampicin 300 mg aktiv substans; laktosmonohydrat hjälpämne - rifampicin
rimactan 300 mg kapsel, hård
paranova läkemedel ab - rifampicin - kapsel, hård - 300 mg - propylenglykol hjälpämne; laktosmonohydrat hjälpämne; rifampicin 300 mg aktiv substans - rifampicin
rifampicin orifarm 300 mg kapsel, hård
orifarm ab - rifampicin - kapsel, hård - 300 mg - rifampicin 300 mg aktiv substans; propylenglykol hjälpämne; laktosmonohydrat hjälpämne - rifampicin
voriconazole teva 200 mg filmdragerad tablett
teva sweden ab - vorikonazol - filmdragerad tablett - 200 mg - vorikonazol 200 mg aktiv substans; laktosmonohydrat hjälpämne; glycerol hjälpämne - vorikonazol
voriconazole sandoz 200 mg filmdragerad tablett
sandoz a/s - vorikonazol - filmdragerad tablett - 200 mg - laktosmonohydrat hjälpämne; vorikonazol 200 mg aktiv substans - vorikonazol
voriconazole teva 50 mg filmdragerad tablett
teva sweden ab - vorikonazol - filmdragerad tablett - 50 mg - vorikonazol 50 mg aktiv substans; laktosmonohydrat hjälpämne; glycerol hjälpämne - vorikonazol
pepcid duo tuggtablett
mcneil sweden ab - famotidin; kalciumkarbonat; magnesiumhydroxid - tuggtablett - famotidin 10 mg aktiv substans; glukosmonohydrat hjälpämne; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; magnesiumhydroxid 165 mg aktiv substans; kalciumkarbonat 800 mg aktiv substans - kombinationer
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
tybost
gilead sciences ireland uc - cobicistat - hiv-infektioner - antivirala medel för systemisk användning - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.